ARTICLE | Clinical News
Sebelipase alfa: Completed Phase II/III enrollment
January 13, 2014 8:00 AM UTC
Synageva completed enrollment of 9 infants with early onset LAL deficiency in an open-label, international Phase II/III trial evaluating weekly IV sebelipase alfa. Preliminary data will be presented a...